Those in favor of the classification argue that excess fat accumulation/distribution is linked to sustained and serious ...

Lexicon Pharmaceuticals Inc. said March 28 it will exclusively license its drug candidate LX9851 to Danish pharmaceutical ...

Salt makes almost everything taste better - we add it while cooking to enhance the flavor of other ingredients, sprinkle some ...

The two market leaders are targeting new obesity alternatives in their pipelines with an eye toward a triple threat.

At a fundraising event, Bucks co-owner Wes Edens spoke on fighting obesity in Milwaukee, his playoff outlook, NBA expansion ...

Cross-sectional studies and Mendelian randomization show that insulin resistance and chronic inflammation mediate the ...

The pleasure we get from eating junk food—the dopamine rush from crunching down on salty, greasy French fries and a luscious ...

The drug tirzepatide improved kidney function and cardiovascular outcomes among patients with obesity and heart failure with ...

Combination treatment with a GLP-1 agonist and thiazolidinedione in type 2 diabetes was tied to a significantly lower risk of ...

We know that kids of color have worse outcomes in school in America. And kids in low income areas. And kids who don’t speak ...

A Prime Therapeutics analysis of real-world data has found that medical costs for patients taking GLP-1 drugs for obesity had increased by about $1,338 per member, compared with a matched control ...

Mexico says a government-sponsored junk food ban in schools has taken effect as the country tries to tackle one of the ...